Carbylan Therapeutics (NASDAQ: CBYL) filed with the U.S. SEC for an IPO of its common stock. The proposed maximum offering ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE